Vaccination against hepatitis A: control 3 years after the first vaccination

First-line ET plus palbociclib versus standard mono-chemotherapy in high-risk HR-positive/HER2-negative metastatic breast cancer and indication for chemotherapy: primary results from the randomized phase IV PADMA study.

ESMO open·2026

Clinical and molecular biomarkers for prediction of endocrine response after short preoperative endocrine therapy in the WSG ADAPT-HR+/HER2- and ADAPTcycle trials (N = 7914).

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX).

ESMO open·2025

Long-term outcome data for patients with hormone receptor-positive early breast cancer participating in the WSG PlanB trial after preselection by gene expression analysis: 10-year survival results from the WSG PlanB registry.

ESMO open·2025

Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292).

ESMO open·2025

Prediction of survival after de-escalated neoadjuvant therapy in HER2-positive early breast cancer: a pooled analysis of three WSG trials.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

Synergistic effect of AddaS03 and poly I:C adjuvants on antibody titers and Th1-biased T cell responses following RBD vaccination in BALB/c mice.

Vaccine·2026

Systematic review of the mutations in the active antigenic site Ø of the prefusion F protein of the Respiratory Syncytial Virus (RSV) following the implementation of monoclonal antibody prophylaxis.

Vaccine·2026

Elevating immunization as a political and economic priority in Africa: Reflections from the continental consensus on Africa's continental immunization strategy in november 2025 in Kigali, Rwanda.

Vaccine·2026

Scaling up vaccination for people living in prisons: a global person-centred need for public health.

Vaccine·2026

A health-economic assessment of the impact of different RSVpreF maternal vaccine strategies to prevent RSV infections among young infants, in France: EPIPACT.

Vaccine·2026

Ethiopia missed opportunities for vaccination study: Cluster-randomized evaluation of 5-dose measles vaccine vials and a flexible open-vial policy, 2021-2022.

Vaccine·2026

What drives adult vaccine hesitancy? Content and face validation of a new measure for U. S. Adults.

Frontiers in public health·2026

Three decades of the health promoting prison: a critical reappraisal of policy and practice.

International journal of prison health·2026

Implementing quality in hospitals - stakeholders' roles: A qualitative social network analysis.

Health SA = SA Gesondheid·2026

Coevolutionary vaccination dynamics driven by committed influencers on complex networks.

Chaos (Woodbury, N.Y.)·2026

Quantifying Influence: The Orthopaedic PAC's Impact Explored Through Analysis of FEC Data.

Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews·2026

Institutionalizing family care responsibility in China's multilevel medical security system: evidence from long-term care insurance policy texts through a Confucian care ethics lens.

Frontiers in public health·2026

Related Experiment Videos

Vaccination against hepatitis A: control 3 years after the first vaccination

Related Concept Videos

First-line ET plus palbociclib versus standard mono-chemotherapy in high-risk HR-positive/HER2-negative metastatic breast cancer and indication for chemotherapy: primary results from the randomized phase IV PADMA study.

Clinical and molecular biomarkers for prediction of endocrine response after short preoperative endocrine therapy in the WSG ADAPT-HR+/HER2- and ADAPTcycle trials (N = 7914).

Long-term effect of neoadjuvant denosumab treatment in high-risk early breast cancer (GeparX).

Long-term outcome data for patients with hormone receptor-positive early breast cancer participating in the WSG PlanB trial after preselection by gene expression analysis: 10-year survival results from the WSG PlanB registry.

Endocrine response assessment in HR-positive HER2-negative early breast cancer: concordance of local versus central Ki67 measurements in the WSG ADAPTcycle trial (n = 5292).

Prediction of survival after de-escalated neoadjuvant therapy in HER2-positive early breast cancer: a pooled analysis of three WSG trials.

Synergistic effect of AddaS03 and poly I:C adjuvants on antibody titers and Th1-biased T cell responses following RBD vaccination in BALB/c mice.

Systematic review of the mutations in the active antigenic site Ø of the prefusion F protein of the Respiratory Syncytial Virus (RSV) following the implementation of monoclonal antibody prophylaxis.

Elevating immunization as a political and economic priority in Africa: Reflections from the continental consensus on Africa's continental immunization strategy in november 2025 in Kigali, Rwanda.

Scaling up vaccination for people living in prisons: a global person-centred need for public health.

A health-economic assessment of the impact of different RSVpreF maternal vaccine strategies to prevent RSV infections among young infants, in France: EPIPACT.

Ethiopia missed opportunities for vaccination study: Cluster-randomized evaluation of 5-dose measles vaccine vials and a flexible open-vial policy, 2021-2022.

What drives adult vaccine hesitancy? Content and face validation of a new measure for U. S. Adults.

Three decades of the health promoting prison: a critical reappraisal of policy and practice.

Implementing quality in hospitals - stakeholders' roles: A qualitative social network analysis.

Coevolutionary vaccination dynamics driven by committed influencers on complex networks.

Quantifying Influence: The Orthopaedic PAC's Impact Explored Through Analysis of FEC Data.

Institutionalizing family care responsibility in China's multilevel medical security system: evidence from long-term care insurance policy texts through a Confucian care ethics lens.

Related Experiment Videos

Vaccination against hepatitis A: control 3 years after the first vaccination

Related Concept Videos

Related Articles